Cytek Biosciences, Inc. (CTKB) — Stock Score Summary

Cytek Biosciences, Inc. (CTKB) has a MoatMap StockRank of 49/100 based on Quality (45/100), Value (43/100), and Momentum (47/100) factor scores. The current signal is HOLD. Cytek Biosciences is a life sciences instrument company. It lacks the recurring revenue profile, regulatory moat, and pricing power of our preferred CDMO gatekeepers.

Cytek Biosciences, Inc. develops and markets proprietary flow cytometry solutions, including instruments, reagents, and software, for cell analysis in research and clinical settings. Its Full Spectrum Profiling (FSP™) technology offers superior multi-parametric analysis with enhanced sensitivity and resolution compared to conventional cytometers, creating a technological advantage. Cytek is a rapidly growing player, disrupting traditional technologies with its innovative platform for deeper cell insights.

Key Financial Metrics

Price$4.13
Market Cap$532M
P/E (Forward)22.79
Price/Book1.71
Return on Equity-20.9%
Return on Invested Capital-7.7%
Debt/Equity8.39
Gross Margin51.7%
Operating Margin-41.8%
Revenue Growth6.5%
Free Cash Flow$6M

Cytek Biosciences, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Cytek Biosciences, Inc.’s (CTKB) StockRank?
MoatMap’s StockRank for Cytek Biosciences, Inc. (CTKB) is 49/100, with a Hold signal. It is a composite of Quality (45), Value (43), and Momentum (47) factor ranks across MoatMap’s 19,000+ stock universe.
Does Cytek Biosciences, Inc. have an economic moat?
Cytek Biosciences, Inc. (CTKB) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cytek Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Cytek Biosciences, Inc. (CTKB) is Hold, based on a StockRank of 49/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cytek Biosciences, Inc. in?
Cytek Biosciences, Inc. (CTKB) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksCTKB deep dive reportAI ChampionsHow we score stocksSense-check another stock